GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a significant focus in healthcare studies, largely due to its remarkable impact on managing ailments such as second type diabetes and obesity. Ongoing research have demonstrated that more than glucose regulation, GLP-1 medications offer promise for cardiovascular well-b